|
Prescription Drug Search
Product Request Form
Folotyn is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Folotyn becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #
Information about ExpressMedsCanada.com
List of countries where we can ship Folotyn:
- Algeria
- Anguilla
- Antigua and Barbuda
- Argentina
- Austria
- Bahrain
- Belarus
- Bermuda
- Bolivia
- Chile
- Cuba
- Czech Republic
- Dominican Republic
- Egypt
- Estonia
- Finland
- Gibraltar
- Guatemala
- India
- Iran
- Jamaica
- Kuwait
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Mauritius
- Netherlands Antilles
- Panama
- Russian Federation
- Spain
- Sri Lanka
- Switzerland
- Tunisia
- Turkey
- Ukraine
- United Arab Emirates
- United Kingdom, UK
- United States, US
- Vanuatu
Latest news releases on Folotyn:
Spectrum extends tender offer for Allos Therapeutics amid FTC inquiry - The Business Journal
Allos investors also would be entitled to another 11 cents if Allos' lymphoma drug Folotyn hits certain milestones in Europe for regulatory approval and sales. Allos shares, which closed at $1.43 the day before Spectrum announced its offer ...
Allos Therapeutics (Graphic: Business Wire) - TheStreet.com
which entitles Allos stockholders to an additional payment of $0.11 per share in cash if certain European regulatory approval and commercialization milestones for FOLOTYN® are achieved. The extension was made in order for Spectrum and Allos to ...
Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics - Yahoo Finance
Allos is currently focused on the development and commercialization of FOLOTYN ® (pralatrexate injection), a folate analog metabolic inhibitor. FOLOTYN is approved in the U.S. for the treatment of patients with relapsed or refractory peripheral ...
SPECTRUM PHARMACEUTICALS, INC. : Spectrum Pharmaceuticals and Allos Therapeutics.. - 4-traders (press release)
Allos is currently focused on the development and commercialization of FOLOTYN® (pralatrexate injection), a folate analog metabolic inhibitor. FOLOTYN is approved in the U.S. for the treatment of patients with relapsed or refractory peripheral T-cell ...
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - PR-USA.net
Pralatrexate (Folotyn), Raloxifene (Evista), Ramucirumab, Ridaforolimus (MK-8669), Sorafenib (Nexavar), Trastuzumab (Herceptin), Trastuzumab biosimilar, Trastuzumab emtansine (T-DM1), Trilostane, Triptorelin, TVAX cancer vaccine, Varlitinib, Veliparib ...
